Eradication versus control for poliomyelitis: an economic analysis KM Thompson, RJD Tebbens The Lancet 369 (9570), 1363-1371, 2007 | 212 | 2007 |
Risks of paralytic disease due to wild or vaccine‐derived poliovirus after eradication RJD Tebbens, MA Pallansch, OM Kew, VM Cáceres, H Jafari, SL Cochi, ... Risk Analysis 26 (6), 1471-1505, 2006 | 178 | 2006 |
Economic analysis of the global polio eradication initiative RJD Tebbens, MA Pallansch, SL Cochi, SGF Wassilak, J Linkins, ... Vaccine 29 (2), 334-343, 2010 | 154 | 2010 |
Expert review on poliovirus immunity and transmission RJ Duintjer Tebbens, MA Pallansch, KM Chumakov, NA Halsey, T Hovi, ... Risk Analysis 33 (4), 544-605, 2013 | 122 | 2013 |
Retrospective cost‐effectiveness analyses for polio vaccination in the United States KM Thompson, RJD Tebbens Risk Analysis 26 (6), 1423-1440, 2006 | 116 | 2006 |
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future RJD Tebbens, MA Pallansch, OM Kew, VM Cáceres, RW Sutter, ... American Journal of Epidemiology 162 (4), 358-372, 2005 | 116 | 2005 |
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine‐derived polioviruses (cVDPVs) RJ Duintjer Tebbens, MA Pallansch, JH Kim, CC Burns, OM Kew, ... Risk analysis 33 (4), 680-702, 2013 | 110 | 2013 |
Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine‐related polioviruses RJ Duintjer Tebbens, MA Pallansch, DA Kalkowska, SGF Wassilak, ... Risk Analysis 33 (4), 703-749, 2013 | 103 | 2013 |
Safety first for automated driving M Wood, P Robbel, M Maass, RD Tebbens, M Meijs, M Harb, J Reach, ... Aptiv, Audi, BMW, Baidu, Continental Teves, Daimler, FCA, HERE, Infineon …, 2019 | 102 | 2019 |
Modeling the dynamics of oral poliovirus vaccine cessation KM Thompson, RJ Duintjer Tebbens The Journal of infectious diseases 210 (suppl_1), S475-S484, 2014 | 97 | 2014 |
Using system dynamics to develop policies that matter: global management of poliomyelitis and beyond KM Thompson, RJD Tebbens System Dynamics Review: The Journal of the System Dynamics Society 24 (4 …, 2008 | 92 | 2008 |
Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs RJ Duintjer Tebbens, MA Pallansch, KM Chumakov, NA Halsey, T Hovi, ... Risk Analysis 33 (4), 606-646, 2013 | 89 | 2013 |
Modeling population immunity to support efforts to end the transmission of live polioviruses KM Thompson, MA Pallansch, RJD Tebbens, SG Wassilak, SL Cochi Risk Analysis, 2012 | 83 | 2012 |
An economic analysis of poliovirus risk management policy options for 2013–2052 RJ Duintjer Tebbens, MA Pallansch, SL Cochi, SGF Wassilak, ... BMC Infectious Diseases 15, 1-21, 2015 | 79 | 2015 |
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation KM Thompson, RJD Tebbens Expert Review of Vaccines 11 (4), 449-459, 2012 | 79 | 2012 |
Evaluation of response scenarios to potential polio outbreaks using mathematical models KM Thompson, RJ Duintjer Tebbens, MA Pallansch Risk Analysis 26 (6), 1541-1556, 2006 | 76 | 2006 |
The risks, costs, and benefits of possible future global policies for managing polioviruses KM Thompson, RJD Tebbens, MA Pallansch, OM Kew, RW Sutter, ... American journal of public health 98 (7), 1322-1330, 2008 | 73 | 2008 |
Rule-based optimal control for autonomous driving W Xiao, N Mehdipour, A Collin, AY Bin-Nun, E Frazzoli, RD Tebbens, ... Proceedings of the ACM/IEEE 12th International Conference on Cyber-Physical …, 2021 | 71 | 2021 |
Optimal vaccine stockpile design for an eradicated disease: Application to polio RJD Tebbens, MA Pallansch, JP Alexander, KM Thompson Vaccine 28 (26), 4312-4327, 2010 | 69 | 2010 |
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013 DA Kalkowska, RJ Duintjer Tebbens, I Grotto, LM Shulman, E Anis, ... The Journal of infectious diseases 211 (11), 1800-1812, 2015 | 67 | 2015 |